Search results
Encompass Health (EHC) JV Opens Atlanta Rehabilitation Hospital
Zacks via Yahoo Finance· 2 hours agoThe new hospital in Atlanta, GA, will help patients recover from amputations, brain injuries,...
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 3 hours agoEisai recorded nearly $19 million in sales from Leqembi in the first quarter. Sales nearly tripled...
AmplifyBio and Xcell enter TCR T-cell therapy manufacturing deal
Pharmaceutical Technology via Yahoo Finance· 3 days agoXcell previously developed the AVATAR incubator system, which is instrumental in cell and gene ...
ASCO: Combination therapy significantly improves o | Newswise
Newswise· 14 hours agoThe median progression-free survival, which is the amount of time during and after treatment when the cancer does not worsen or progress, with the combination treatment was 6.2 months compared ...
Candel (CADL) Reports Upbeat Data From Lung Cancer Study
Zacks via Yahoo Finance· 3 hours agoCandel's (CADL) CAN-2409 prolongs overall survival in a phase II study for treating patients with...
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
Morningstar· 1 day agoAmerican:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, recently released a white ...
Study identifies differences in prostate cancer genomics among a racially and ethnically diverse...
Medical Xpress· 21 minutes agoAfter adjusting for a number of individual patient-level factors, including the type of cancer...
Pup rally: First lady Justice introduces new therapy dog
The Marietta Times· 2 days agoBarney the therapy dog poses with the Parkersburg High School cheer squad after First Lady Cathy...
Medical center adds miniature horse as latest therapy animal helping patients
WCAX-TV Vermont· 3 days agoA hospital in Arizona has added a new four-legged volunteer to their animal-assisted therapy...
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy...